PUBLICATIONS · 29438093
FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non-Small Cell Lung Cancers Harboring BRAF V600E Mutations.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Oncologist
- Publication date
- 2018 Jun
- First author
- Odogwu L
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Odogwu L
- type
- Author
- name
- Mathieu L
- type
- Author
- name
- Blumenthal G
- type
- Author
- name
- Larkins E
- type
- Author
- name
- Goldberg KB
- type
- Author
- name
- Griffin N
- type
- Author
- name
- Bijwaard K
- type
- Author
- name
- Lee EY
- type
- Author
- name
- Philip R
- type
- Author
- name
- Jiang X
- type
- Author
- name
- Rodriguez L
- type
- Author
- name
- McKee AE
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Odogwu L
- type
- Author
- name
- Mathieu L
- type
- Author
- name
- Blumenthal G
- type
- Author
- name
- Larkins E
- type
- Author
- name
- Goldberg KB
- type
- Author
- name
- Griffin N
- type
- Author
- name
- Bijwaard K
- type
- Author
- name
- Lee EY
- type
- Author
- name
- Philip R
- type
- Author
- name
- Jiang X
- type
- Author
- name
- Rodriguez L
- type
- Author
- name
- McKee AE
- type
- Author
- bibliography ids
- nci-bib-8c27b2ef81e9eb42048aaca9
- book metadata
- content sha256
- 106f14e1ab3c870c31c5ae9a4d34b3009201a88e5bd2fc08e5c17747f6961549
- document type
- citation
- dois
- 10.1634/theoncologist.2017-0642
- electronic publication date
- display
- 2018 Feb 7
- precision
- day
- year
- 2018
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:29438093
- immutable id
- pubmed:29438093@106f14e1ab3c870c31c5ae9a4d34b3009201a88e5bd2fc08e5c17747f6961549
- journal
- abbreviation
- Oncologist
- issn electronic
- 1549-490X
- issn print
- 1083-7159
- issue
- 6
- name
- The oncologist
- nlm unique id
- 9607837
- pages
- 740-745
- volume
- 23
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 29438093
- provenance
- batch id
- ec9444d0f4cade22eb9f
- provider
- NCBI PubMed ESummary
- record sha256
- f0ae471a36670a2047f23fce0017080996197264653bf5751ecfc7df75c2c616
- response sha256
- 6eef0d8cc09b77e73af656f6390cc734befb84fbc4c229b886e81e5d95bece31
- retrieved at
- 2026-09-09T23:47:30.975610+00:00
- publication date
- display
- 2018 Jun
- precision
- month
- year
- 2018
- publication types
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non-Small Cell Lung Cancers Harboring BRAF V600E Mutations.
Preserved source evidence · Not medical advice
Triangle